Boothbay Fund Management, LLC Boston Scientific Corp Transaction History

Boothbay Fund Management, LLC

$4.45 Billion
Q2 2025

A detailed history of Boothbay Fund Management, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 2,396 shares of BSX stock, worth $232,483. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,396

Previous 3,896 38.5%

Holding current value

$232,483

Previous $393,000 34.61%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 14, 2025	SELL	$89.7 - $107.41 $134,550 - $161,115	-1,500 Reduced 38.5%	2,396 $257,000
Q1 2025 May 15, 2025	SELL	$89.38 - $106.18 $2.88 Million - $3.42 Million	-32,238 Reduced 89.22%	3,896 $393,000
Q4 2024 Feb 14, 2025	SELL	$83.62 - $91.5 $5.7 Million - $6.24 Million	-68,182 Reduced 65.36%	36,134 $3.23 Million
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $4.22 Million - $4.86 Million	57,846 Added 124.48%	104,316 $8.74 Million
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $806,209 - $930,499	11,974 Added 34.71%	46,470 $3.58 Million
Q1 2024 May 15, 2024	BUY	$57.6 - $68.62 $1.38 Million - $1.64 Million	23,917 Added 226.08%	34,496 $2.36 Million
Q4 2023 Feb 14, 2024	SELL	$48.64 - $57.81 $5.25 Million - $6.24 Million	-107,937 Reduced 91.07%	10,579 $611,000
Q3 2023 Nov 14, 2023	SELL	$50.19 - $54.68 $941,313 - $1.03 Million	-18,755 Reduced 13.66%	118,516 $6.26 Million
Q2 2023 Aug 14, 2023	SELL	$49.72 - $54.64 $3 Million - $3.29 Million	-60,241 Reduced 30.5%	137,271 $7.42 Million
Q1 2023 May 15, 2023	SELL	$45.09 - $50.03 $3.63 Million - $4.03 Million	-80,532 Reduced 28.96%	197,512 $9.88 Million
Q4 2022 Feb 14, 2023	SELL	$39.56 - $47.22 $5.99 Million - $7.15 Million	-151,350 Reduced 35.25%	278,044 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $814,227 - $2.43 Million	22,180 Added 5.45%	429,394 $16.6 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $6.15 Million - $8.22 Million	174,581 Added 75.05%	407,214 $15.2 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $2.79 Million - $3.08 Million	68,301 Added 41.56%	232,633 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $1.17 Million - $1.38 Million	30,785 Added 23.05%	164,332 $6.98 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $4.15 Million - $4.62 Million	100,622 Added 305.61%	133,547 $5.8 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $280,978 - $322,199	-7,283 Reduced 18.11%	32,925 $1.41 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $4.9 Million - $5.51 Million	-138,792 Reduced 77.54%	40,208 $1.55 Million
Q4 2020 Feb 12, 2021	BUY	$33.15 - $41.97 $5.13 Million - $6.49 Million	154,745 Added 637.99%	179,000 $6.44 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $42.23 $158,148 - $193,920	-4,592 Reduced 15.92%	24,255 $927,000
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $76,561 - $99,182	2,536 Added 9.64%	28,847 $1.01 Million
Q1 2020 May 15, 2020	BUY	$25.83 - $45.71 $679,613 - $1.2 Million	26,311 New	26,311 $859,000
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $236,801 - $283,698	-6,253 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $252,058 - $271,692	6,253 New	6,253 $254,000
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $177,688 - $218,624	-5,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $183,848 - $216,328	5,600 New	5,600 $216,000
Q1 2018 May 14, 2018	SELL	$25.2 - $28.54 $372,607 - $421,992	-14,786 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $366,544 - $440,622	14,786	14,786 $367,000

Others Institutions Holding BSX

# of Institutions

1,909

Shares Held

1.27B

Call Options Held

9.71M

Put Options Held

7.17M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $139B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Account

Boothbay Fund Management, LLC Boston Scientific Corp Transaction History